Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting

The ability to successfully develop a safe and effective vaccine for the prevention of HIV infection has proven challenging. Consequently, alternative approaches to HIV infection prevention have been pursued, and there have been a number of successes with differing levels of efficacy. At present, on...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, Joseph W., Baum, Marc M., Demkovich, Zach R., Diana, Frank, Dobard, Charles, Feldman, Paul L., Garcia-Lerma, J. Gerardo, Grattoni, Alessandro, Gunawardana, Manjula, Ho, Duy-Khiet, Hope, Thomas J., Massud, Ivana, Milad, Mark, Moss, John A., Pons-Faudoa, Fernanda P., Roller, Shane, van der Straten, Ariane, Srinivasan, Selvi, Veazey, Ronald S., Zane, Doris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213003/
https://www.ncbi.nlm.nih.gov/pubmed/33913760
http://dx.doi.org/10.1089/aid.2021.0028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213003/
https://www.ncbi.nlm.nih.gov/pubmed/33913760
http://dx.doi.org/10.1089/aid.2021.0028

Ejemplares similares